NFKB1 and metabolic dysfunction-associated steatotic liver disease: Persistent activation of the JNK and NF-κB pathways worsens insulin resistance and leads to a chronic inflammatory state and to the activation of apoptosis, fostering liver injury and NAFLD progression toward NASH [231,232,233,234,235].